TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers at the Netherlands Institute for Neuroscience found that immature neurons were present in brain samples from older adults, including people with Alzheimer’s pathology who remained cognitively resilient. Those cells showed activity associated with survival and lower inflammation and cell-death signals, suggesting their behavior—not simply their number—could be relevant. The study does not establish that the cells cause resilience or that adult human brains are making new neurons.
Researchers at the Netherlands Institute for Neuroscience report that immature neurons in brain samples from people who stayed mentally sharp despite Alzheimer’s pathology showed activity linked to cell survival and protection from damage. The finding offers a possible clue to cognitive resilience, but it does not show that the cells caused the participants’ preserved thinking or that they were newly produced in adulthood.
The team examined donated tissue from the Netherlands Brain Bank, comparing people without detectable brain pathology, people with Alzheimer’s dementia, and people whose brains showed Alzheimer’s-related changes but who had remained cognitively resilient. Researchers focused on a small region in the brain’s memory center where new neurons have been proposed to develop. They said the cells were rare and required targeted methods to identify.
Immature neurons appeared in all three groups, including in samples from older adults whose average age was over 80, according to senior author Evgenia Salta. The researchers had expected resilient people might have substantially more of these cells if they helped replace neurons lost to disease. Instead, the difference in cell numbers was smaller than expected.
The reported distinction was in the cells’ activity. In resilient individuals, immature neurons showed signs of activating processes associated with survival and coping with damage, alongside lower signals related to inflammation and cell death. The researchers suggest the cells might support surrounding brain tissue as well as, or instead of, replacing lost neurons. These are interpretations of biological signals in the samples, not evidence that the proposed support function has been demonstrated in living people.
Why Neuron Activity May Matter
The findings shift attention from simply asking whether resilient brains contain more immature neurons to asking how those cells behave. If further work supports the interpretation, resilience may involve the ways brain cells withstand disease-related stress or help maintain the tissue around them, rather than a greater supply of replacement cells alone.
That possibility matters because Alzheimer’s pathology and dementia do not align in the same way for everyone. A person can show disease-associated changes in the brain without experiencing the same level of memory and thinking problems as another person. Understanding this difference could help researchers investigate protective biological processes alongside the processes that damage brain networks. The study does not identify a treatment, establish a way to increase resilience, or show that changing these cell processes would prevent dementia.
Products Worth Considering
Levoit Core 400S-P Smart Air Purifier for Large Rooms
Levoit Eleva 300X HEPA Air Purifier for Home and Bedroom
Withings BPM Vision Blood Pressure Monitor with Wi-Fi and Bluetooth
As an affiliate, we earn on qualifying purchases.
The Human Neurogenesis Question
Adult neurogenesis is the production of new neurons in an adult brain. It is established in several animal species, but whether it continues in the adult human brain has been debated for decades. The presence of immature-looking cells is relevant to that question, but it does not by itself prove that they were recently formed. They could be cells with immature features whose origin or development cannot be established from this observation alone.
Salta said the research addressed the rarity of the cells by focusing on a narrowly defined brain region and developing methods to identify them more precisely, rather than relying heavily on assumptions based on animal studies. The comparison among three groups allowed the team to examine the cells in relation to both Alzheimer’s pathology and dementia. The reported work is an analysis of donated tissue, not a test of how the cells behave over time in a living human brain.
“Around 30 percent of older adults who develop Alzheimer’s disease never experience its symptoms.”
— Evgenia Salta, senior author
What the Tissue Cannot Show
The study cannot establish whether immature neurons directly help preserve cognition, whether their activity changes in response to other differences in the brain, or whether the observed signals are a consequence rather than a cause of resilience. Because the analysis used donated tissue, it also cannot track cell behavior or cognitive change over time in the same people.
Finding immature neurons does not prove adult neurogenesis: the researchers would need evidence that the cells were recently generated to answer that question. The source report does not specify the number of participants, detailed effect sizes, or whether the observed activity patterns were independently replicated. It also remains unclear what signals might prompt the apparent protective activity and whether the proposed support for neighboring tissue occurs in a living brain.
Testing the Protective Cell Signals
The next research step is to test whether the activity patterns seen in resilient brain samples can be reproduced and tied more directly to preserved brain function. Further work would need to clarify the cells’ origin, what biological processes drive their survival-related activity, and whether they affect nearby neurons or brain tissue.
Until those questions are answered, the findings should be treated as a potential clue about resilience, not a demonstrated mechanism or a basis for clinical care. The report describes no planned trial, treatment, or specific next milestone. Researchers will need additional evidence before concluding whether immature neurons could inform strategies to protect cognition in people affected by Alzheimer’s disease.
Key Questions
What did the researchers find?
They found immature neurons in all three groups of donated brain samples and reported that these cells showed activity associated with survival and lower inflammation and cell-death signals in cognitively resilient individuals with Alzheimer’s pathology.
Does the study prove that these cells prevent Alzheimer’s dementia?
No. The study reports differences in cells from donated tissue and suggests a possible link with resilience. It does not show that the cells caused people to remain cognitively healthy.
Does finding immature neurons prove the adult brain makes new neurons?
No. Cells that look immature do not by themselves show that they were recently produced. Whether adult human brains continue to generate new neurons remains debated.
Were resilient participants found to have many more immature neurons?
No substantial difference in cell numbers was reported. The researchers said the more notable contrast was in the cells’ activity, including signals linked to survival and protection from damage.
Could this finding lead to a treatment?
The report does not describe a treatment or establish that altering these cells would protect cognition. Further studies are needed to test the proposed role and determine whether it has clinical relevance.
Source: rss
